C
CathVision
Health Tech & Medtech · Copenhagen, Denmark · Founded 2010
Ablation therapy of cardiac arrhythmia with novel hardware, software and data science MoreLess
CathVision is a pioneering startup focused on advancing the field of cardiac electrophysiology, specifically targeting the treatment of cardiac arrhythmias. The company is dedicated to empowering electrophysiologists—specialists who study and treat the electrical activities of the heart—to more effectively diagnose and cure arrhythmias. Cardiac arrhythmias, such as atrial fibrillation, affect approximately 20 million people globally and are associated with severe health issues like strokes and heart failure.
CathVision operates in the medical technology market, particularly within the niche of interventional electrophysiology. The company's flagship product, the CathVision Cube, is designed to record high-quality intracardiac electrograms. These are electrical signals from within the heart that help doctors distinguish between true clinical signals and artifacts (false signals). This differentiation is crucial for the success of procedures like ablation, a treatment that aims to cure arrhythmias by destroying the tissue causing the irregular heartbeat.
The business model of CathVision revolves around developing and providing cutting-edge medical devices to hospitals and clinics. Currently, their product is in the investigational stage, meaning it is being tested and is not yet available for commercial sale. The company is actively seeking partnerships with hospitals for a limited market release to further evaluate their product's effectiveness.
CathVision generates revenue through funding and grants, notably from the European Union's Horizon 2020 research and innovation program. This funding supports the development and testing of their medical devices. Once the product is commercially available, the company will likely generate income through direct sales to hospitals and clinics, as well as potential licensing agreements.
In summary, CathVision is a medical technology startup focused on improving the diagnosis and treatment of cardiac arrhythmias through advanced electrophysiology tools. Their innovative approach aims to enhance the precision and effectiveness of heart treatments, ultimately benefiting millions of patients worldwide.
Keywords: Cardiac, Electrophysiology, Arrhythmia, Medical Device, Innovation, Hospitals, Ablation, Intracardiac Electrograms, Horizon 2020, Healthcare.
Company overview
CathVision company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2010
- Headquarters
- Copenhagen, Denmark
- Employees
- 40
- Open positions
- 1
- Dealroom signal
- 74.1
Valuation & funding
CathVision funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SUPPORT PROGRAM✓Other financing | Oct 2025 | $0 | — | HealthTech Arkansas · MedAxiom · HeartX | ↗ |
| LATE VC✓Equity / VC | Jul 2023 | $9M | $71M | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Aug 2022 | $7.2M | $71M | Undisclosed | ↗ |
| SECONDARY✓Other financing | Jan 2021 | $0 | — | Nordic Secondary Fund | ↗ |
| LATE VC✓Equity / VC | May 2020 | $14M | $57M | Undisclosed | ↗ |
| GRANTOther financing | Oct 2019 | European Commission | — | ||
| EARLY VC✓Equity / VC | Jul 2017 | Borean Innovation | — | ||
| SEED✓Equity / VC | Dec 2015 | Innovation Fund Denmark · Borean Innovation | — | ||
| SEED✓Equity / VC | Apr 2014 | Market Maturation Fund · Borean Innovation | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | EBITDA | Margin | Profit | Margin | R&D |
|---|---|---|---|---|---|
| 2026 | −$3.2M | — | −$5.7M | — | $0 |
| 2025 | −$3.2M | — | −$5.7M | — | $0 |
| 2024 | −$3.2M | — | −$5.7M | — | $0 |
| 2023 | −$3.2M | — | $0 | ||
| 2022 | −$3.2M | — | |||
| 2021 | −$1.3M | — | |||
| 2020 | −$1M | — |
Growth signals
CathVision website traffic
Latest recorded traffic for CathVision is 1.8K monthly website visits, up 100% over the last three months. CathVision's team grew 0% over the past year.
Hiring
Open positions at CathVision
Current openings linked to this company in Dealroom.
Comparisons
CathVision compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
IdovenAI-powered platform for rapid, accurate electrocardiogram analysis |
Majadahonda, Spain | Operational | 68 | $21M | $53M |
inHEARTAI-enabled digital twin of the heart |
Pessac, France | Operational | |||
MVision AIOffers solution for modern cancer radiation therapy treatment through innovative AI technology |
Helsinki, Finland | Operational | |||
UltromicsAI-powered echocardiogram analysis for heart failure detection. |
Oxford, United Kingdom | Operational | |||
QuantibMachine learning medical imaging applications to make more accurate diagnoses more efficiently |
Rotterdam, Netherlands | Acquired | |||
AZmedThe first French company to commercialize an AI-powered radiology software |
Paris, France | Operational | |||
NicolabNicolab developed StrokeViewer® to enable fast and accurate image analysis that helps physicians in making well-informed decisions |
Amsterdam, Netherlands | Operational | |||
IcometrixAI-powered software for quantitative brain scan analysis |
Leuven, Belgium | Acquired |
Talent graph
CathVision's talent
Source: Dealroom Talent Intelligence.
Investors
9 investors on CathVision's cap table
Sourced from Dealroom's funding and investor records.







Global footprint
Where CathVision has talent and traffic
team presence
In the news
Latest news about CathVision
Recent press, funding announcements, and product moves mentioning CathVision — open to read from the original sources.
Market sentiment
What the market is saying about CathVision
An AI-synthesized read of the highest-engagement posts about CathVision on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CathVision’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







